VANTAGE CONSULTING GROUP INC – Nektar Therapeutics Transaction History
VANTAGE CONSULTING GROUP INC portfolio value:
$0
portfolio value
VANTAGE CONSULTING GROUP INC quarter portfolio value change:
-15.79%
quarter
Nektar Therapeutics 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -10.67K shares | -41K | $3.2 | 0 |
| Q2 2022 | share | Increase | 0.00% | 10.67K shares | 41K | $3.8 | 10.67K |
| Q1 2021 | share | Decrease | -100.00% | -1.09K shares | -19K | $20 | 0 |
| Q4 2020 | share | Increase | 0.00% | 1.09K shares | 19K | $17 | 1.09K |